Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

著者: Markus Cornberg, Anna Suk‐Fong Lok, Norah A. Terrault, Fabien Zoulim, Thomas Berg, Maurizia Rossana Brunetto, Stephanie Buchholz, Marı́a Buti, Henry Lik‐Yuen Chan, Kyong‐Mi Chang, Maura Dandri, Geoffrey Dusheiko, Jordan J. Feld, Carlo Ferrari, Marc G. Ghany, Harry L.A. Janssen, Patrick Kennedy, Pietro Lampertico, Jake T. Liang, Stephen Locarnini, Mala K. Maini, Poonam Mishra, George Papatheodoridis, Jörg Petersen, Silke Schlottmann, Su Wang, Heiner Wedemeyer - Journal of Hepatology 2019 被引用: 358